Filter
174
Text search:
African
Trypanosomiasis
Featured
Recommendations
16
New Publications
33
Language
Document type
No document type
71
Studies & Reports
58
Guidelines
14
Strategic & Response Plan
13
Manuals
8
Resource Platforms
4
Situation Updates
3
Infographics
1
Videos
1
Fact sheets
1
Countries / Regions
Africa
24
Global
19
Uganda
10
West and Central Africa
9
East and Southern Africa
8
Liberia
7
Middle East and North Africa
5
Sierra Leone
4
South Sudan
4
Zambia
4
Congo, Democratic Republic of
3
Ghana
3
Tanzania
3
South Africa
3
Malawi
3
Latin America and the Carribbean
3
Southern Africa
3
Guinea
2
India
2
Kenya
2
Rwanda
2
Angola
2
Nigeria
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Syria
1
Chad
1
Sudan
1
Benin
1
Botswana
1
El Salvador
1
Libya
1
Yemen
1
Western Pacific Region
1
Western and Central Europe
1
Palestine
1
Djibouti
1
Qatar
1
Iran
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
40
Clinical Guidelines
24
Public Health
20
Capacity Building
6
Women & Child Health
2
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
NTDs
70
Rapid Response
13
Planetary Health
10
Ebola
4
Mental Health
3
Pharmacy
3
NCDs
3
HIV
2
TB
2
AMR
2
Disability
1
Natural Hazards
1
COVID-19
1
Caregiver
1
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human
...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’
...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in
...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci
...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies
...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caus
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor a
...
The Global Campaign Against Epilepsy “Out of the Shadows”
In 2012, the World Health Organisation (WHO) set out a roadmap for the control, elimination, or eradication of 17 neglected tropical diseases by 2020. Many were skeptical about the achievability of such goals. Now, still two years away from that end point, good news is emerging for gambiense human
...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diag
...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati
...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t
...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions
...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including posi
...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underd
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form
...
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei
...
